$281.70
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Country

US

CEO

Dr. Robert Mauch

IPO date

1996

Employees

51,000

ISIN

US03073E1055

Key stats

Open

$283.88

Volume

938.60K

Market cap

$54.77B

Prev. close

$281.48

Impl / hst vl

-

Open interest

$0.00

$279.62

Day’s Range

$283.88

$244.82

52W Range

$374.89

Valuation

38
Valuation score
Overvalued
P/E
23.98
P/S
0.19
P/B
17.99
Current ratio
0.95
Debt / Equity
3.00
ROE
115.93%
Gross margin
4.57%
Income growth
193.28%
FCF growth
-147.37

Jun

1

Dividends

The last payment date was Jun 1, 2026

Div. per Share

$0.60

Div. Yield

0.21%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 11 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$366.61
The top 15 analysts forecasts that 12-month price may increase by 30.14%, with a low of $282.80 and a high of $446.25
$282.80
Low
$366.61
Avg
$446.25
High
Current price

Earnings

Q1 ‘26 revenue
$78.36B
Q1 ‘26 net income
$1.64B
Revenue
Net income
Previous EPS
$4.08
Estimate EPS
$4.86
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply